MIRA INFORM REPORT
|
Report Date : |
06.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
PERFECT MEDICAL INDUSTRY CO., LTD. |
|
|
|
|
Registered Office : |
100 Shin Gong 1Rd, Pei Pou Industrial Park Chang Hwa Hsien |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
17.04.1989 |
|
|
|
|
Com. Reg. No.: |
23243578 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and sales of medical products, etc. |
|
|
|
|
No. of Employees
: |
About 50 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 30,000 |
|
Status : |
Moderate |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
100 Shin Gong 1Rd, Pei Pou Industrial Park
Chang Hwa Hsien, Taiwan R.O.C. |
|
Supplied Address: |
|
|
Telephone Number: |
+886-4-8887998 |
|
Fax Number: |
Notes:
The exact subject’s name and address are as above mentioned.
|
Credit Rating: |
|
|
Credit Opinion: |
Subject was incorporated on 1989-4-17 with registered
number 23243578 as Joint Stock Company in Taiwan.
|
Name |
Subscription
Shares |
|
Guoji Xu |
1,168,094 |
|
Qingsen Zhao |
|
|
265,176 |
|
|
Zhengguo Zhuang |
307,553 |
|
Sunsino Development Associate Inc. |
365,000 |
|
Qingzu Xiao |
206,760 |
|
Shizhi Lin |
848,709 |
|
Quanyu Lin |
324,906 |
|
Xiyi Ye |
656,829 |
|
德陽生物科技創業投資股份有限公司 |
667,984 |
|
Dengzong Lin |
139,668 |
|
Guoyu Li |
9,300 |
The information
above is that of subject’s major shareholders.
Subject did not register any subsidiaries or
branches, from other source we can not obtain the relevant information, either.
Core
Management
|
1 |
|
|
Name |
Guoji Xu |
|
Position |
Chairman |
|
2 |
|
|
Name |
Qingsen Zhao |
|
Position |
Vice-chairman |
|
3 |
|
|
Name |
Zhengguo Zhuang |
|
Position |
Director |
|
Date of
Appointment |
2009-12-25 |
|
4 |
|
|
Name |
Sunsino Development Associate Inc. |
|
Position |
Director |
|
5 |
|
|
Name |
Lin Wei |
|
Position |
Director |
|
6 |
|
|
Name |
Qingzu Xiao |
|
Position |
Director |
|
7 |
|
|
Name |
Shizhi Lin |
|
Position |
Director |
|
8 |
|
|
Name |
Quanyu Lin |
|
Position |
Director |
|
9 |
|
|
Name |
Xiyi Ye |
|
Position |
Director |
|
10 |
|
|
Name |
德陽生物科技創業投資股份有限公司 |
|
Position |
Supervisor |
|
11 |
|
|
Name |
Dengzong Lin |
|
Position |
Supervisor |
|
12 |
|
|
Name |
Guoyu Li |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 50 Employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
100 Shin Gong 1Rd, Pei Pou Industrial Park Chang Hwa Hsien, Taiwan
R.O.C. |
Production
Information
l
Subject produces medical products, etc.
l
Subject has factories both in Taiwan and Vietnem.
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
1 |
Manufacture, process and trading of medical
products |
|
2 |
Manufacturing, processing
and trading of medical blood transfusion, infusion, injection, piercing, implants,
acquisition, perfusion, washing, disinfection, inspection, rehabilitation
supplies, surgical dressings packaging materials |
|
3 |
Classification, packaging,
sterilization, and trading of
treatment package, care packages, surgical gowns, caps, masks, hole
towel, medical catheter |
|
4 |
Cosmetics, chemical raw
materials (except tube products), food, beverages trading business. |
|
5 |
Commodity processing,
classification, storage, waste clean-up operations. |
|
6 |
Manufacture and sales of raw material of above
products |
|
7 |
Import, export and agent of above products |
|
CF01011 |
Medical Equipment
Manufacturing |
|
F108031 |
Wholesales of medical products |
|
F208031 |
Retails of medical products |
|
ZZ99999 |
Besides licensed
business, all other business items those are not banned or restricted. |
l
The components and raw material for production are
purchased from both domestic and abroad.
l
The subject has a
proportion of 50% for Import
l
The subject is mainly engaged in manufacturing and
processing of various medical products.
l
Subject’s products include infusion sets, syringes, dialysis tube needles, blood collection, blood
transfusion sets, scalp acupuncture, extension tubes, medicine bottle, medicine
cup, the blood circuit and other products.
l
Subject has both domestic and foreign markets.
l
Subject exports to Chile, Peru, Bangladesh, Hong
Kong, India, Republic Of Korea, Malaysia, Pakistan, Thailand, Taiwan, Republic
of China, Viet Nam, Brazil, Philippines, etc.
l
The subject has a
proportion of 50% for export.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Payment Terms |
Proportion |
|
|
Raw material |
COD, CBD, etc. |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Raw material |
CBD, etc. |
100% |
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Medical products |
CBD, etc. |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Medical products |
CBD, etc. |
100% |
Subject has no obligations to disclose its financial statements to the
third party according to the relevant policy in Taiwan and the only source from
which we can obtain the information is the subject itself.
Subject’s relevant staff Ms. Zhang declined to disclose its financials
citing the grounds of company’s confidentiality; from other source we can not
obtain the relevant information, either.
Mortgage
No chattel
mortgage record of subject has been found within the recent 3 months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
|
Name |
Ms. Zhang |
|
E-mail |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.79 |
|
UK Pound |
1 |
Rs.78.79 |
|
Euro |
1 |
Rs.65.73 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.